CANF - Can-Fite BioPharma Ltd.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 9.79M
Enterprise Value 1.87M
Trailing P/E N/A
Forward P/E 1.87
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.51
Price/Book (mrq)1.50
Enterprise Value/Revenue 2.30
Enterprise Value/EBITDA -0.19

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-71.24%
S&P500 52-Week Change 33.90%
52 Week High 311.2000
52 Week Low 31.5200
50-Day Moving Average 32.1002
200-Day Moving Average 35.4051

Share Statistics

Avg Vol (3 month) 357.49k
Avg Vol (10 day) 333.67k
Shares Outstanding 54.08M
Implied Shares Outstanding 6N/A
Float 8N/A
% Held by Insiders 10.00%
% Held by Institutions 11.05%
Shares Short (May 14, 2023) 493.34k
Short Ratio (May 14, 2023) 41.43
Short % of Float (May 14, 2023) 4N/A
Short % of Shares Outstanding (May 14, 2023) 42.29%
Shares Short (prior month Apr 13, 2023) 456.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 09, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jan 08, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.30
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)810k
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-3.1200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)1.50

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A